All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Grade 5 Stomach Infection with Unknown Absolute Neutrophil Count, CTCAE | NCIT_C60077 | |
| Grade 5 Trachea Infection Documented Clinically or Microbiologically with Grade 3 or 4 Neutrophils, CTCAE | NCIT_C60078 | |
| Grade 5 Ungual Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE | NCIT_C60082 | |
| Grade 5 Ungual Infection with Unknown Absolute Neutrophil Count, CTCAE | NCIT_C60083 | |
| Grade 5 Upper Aerodigestive Infection NOS Documented Clinically or Microbiologically with Grade 3 or 4 Neutrophils, CTCAE | NCIT_C60084 | |
| Grade 5 Upper Aerodigestive Infection NOS with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE | NCIT_C60085 | |
| Grade 5 Trachea Infection with Unknown Absolute Neutrophil Count, CTCAE | NCIT_C60080 | |
| Grade 5 Ungual Infection Documented Clinically or Microbiologically with Grade 3 or 4 Neutrophils, CTCAE | NCIT_C60081 | |
| Schistosoma Mansoni Infection | NCIT_C35002 | [An infection that is caused by Schistosoma mansoni.] |
| Catatonic Type Schizophrenia | NCIT_C35003 | [A subtype of schizophrenia characterized by a psychomotor disturbance that may involve motoric immobility, excessive motor activity, extreme negativism or mutism, peculiarities of voluntary movement, echolalia, and/or echopraxia.] |
| Childhood Schizophrenia | NCIT_C35004 | [Schizophrenia occurring in childhood.] |
| Disorganized Type Schizophrenia | NCIT_C35005 | [A subtype of schizophrenia characterized by disorganized speech, disorganized behavior, and a flat or inappropriate affect; associated features include grimacing, mannerisms, and other oddities of behavior. Criteria for the catatonic type of schizophrenia are not met.] |
| Thymoma by Masaoka-Koga Stage | NCIT_C112006 | [A staging system for thymoma based on the anatomic extent of disease at the time of surgery.] |
| Thymoma | NCIT_C3411 | [A neoplasm arising from the epithelial cells of the thymus. Although thymomas are usually encapsulated tumors, they may invade the capsule and infiltrate the surrounding tissues or even metastasize to distant anatomic sites. The following morphologic subtypes are currently recognized: type A, type B, type AB, metaplastic, micronodular, microscopic, and sclerosing thymoma. Thymomas type B are further subdivided into types B1, B2, and B3. Thymoma type B3 usually has the most aggressive clinical course.] |
| Masaoka-Koga Stage I | NCIT_C112007 | [The tumor is completely encapsulated.] |
| Masaoka-Koga Stage IIa | NCIT_C112008 | [The tumor shows microscopic invasion into the capsule.] |
| Masaoka-Koga Stage II | NCIT_C115033 | [The tumor shows invasion into the capsule.] |
| Schistosoma Japonicum Infection | NCIT_C35001 | [An infection that is caused by Schistosoma japonicum.] |
| Masaoka-Koga Stage IIb | NCIT_C112009 | [The tumor shows invasion through the capsule and into the surrounding fatty tissue.] |
| Cebranopadol | NCIT_C112002 | [An orally available benzenoid that acts as an opioid peptide receptor agonist for the nociceptin/orphanin FQ peptide receptor (opioid receptor like -1; OPRL1; ORL-1; NOP; kappa-type 3 opioid receptor) and the classical opioid receptors, mu, delta and kappa, with potential anti-nociceptive activity. Upon oral administration, cebranopadol binds to NOP and the mu, delta and kappa opioid receptors, which enhances NOP- and opioid receptor-mediated signaling, interferes with the sensation of pain and results in an analgesic effect. NOP, a member of the opioid receptor family, and its endogenous ligand nociceptin play key roles in the regulation of various brain activities including pain, and some inflammatory and immune responses.] |